Rahul Somvanshi
Boston Scientific, a manufacturer of cardiac stents, pacemakers, neuromodulation implants, and endoscopic visualization equipment, disclosed on August 26 that it discovered a cybersecurity incident affecting its information technology systems. The company detected unauthorized activity on August 25 and activated its incident-response procedures. What happened and what it means remains largely unclear because the company is still investigating.
Boston Scientific supplies hospitals and healthcare facilities worldwide with specialized implantable and procedural devices. The IT disruption has already affected the company’s systems for order processing and shipping of medical devices globally. That disruption carries operational weight. Healthcare facilities depend on supplier order-processing systems to manage inventory for medical procedures.
What Boston Scientific has not disclosed is nearly everything else. The company filed a Form 8-K with the Securities and Exchange Commission on August 26 disclosing the incident. Stock markets responded immediately to the disclosure. Boston Scientific shares fell between 4.6 and 6.0 percent in early trading, with shares reaching approximately $47.57 per share.
